Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Further development and licensing of the Xe-100 remains a significant challenge
R&D Expenses Significant Focused on clinical trials
The platform ensures efficient service delivery to its users
By optimizing e-commerce and digital marketing
Compliance Following guidelines like FDA regulations for medical devices
FRESHA SWOT ANALYSIS TEMPLATE RESEARCH B_61 Further development and licensing ofMake Insightful Decisions Backed by Expert Research Fresha's SWOT highlights strong global marketplace traction and scalable tech, counterbalanced by intense competition and dependence on salon therapist uptake; our full SWOT drills into revenue levers, regulatory risks, and strategic moves to sustain growth. Purchase the complete analysis for a professionally formatted Word report and editable Excel models ready to support investor pitches, strategic
US$ 140.00
US$ 675.00
US$ 175.00
US$ 50.00
